Abstract
This review explores the relationship between vitamin D supplementation and lithogenesis. A causal relationship has been assumed despite myriad studies demonstrating that therapeutic doses of vitamin D do not increase lithogenic risk. Select stone formers may be at increased risk for recurrence with vitamin D supplementation, possibly from CYP24A1 gene mutations. Additionally, the evidence for who is vitamin D deficient, and the benefits of supplementation in those not at risk for rickets, is sparse. Concerns may be avoidable as vitamin D screening appears unnecessary in most patients, and superior pharmacology is available which increases bone density, while decreasing stone formation.
Copyright © 2020 Elsevier Inc. All rights reserved.
MeSH terms
-
Animals
-
Bone Density / drug effects
-
Calcitriol / biosynthesis
-
Calcitriol / metabolism
-
Calcium / administration & dosage
-
Calcium / adverse effects*
-
Calcium / metabolism
-
Cohort Studies
-
Dietary Supplements / adverse effects*
-
Diphosphonates / therapeutic use
-
Female
-
Humans
-
Intestinal Absorption
-
Kidney Calculi / chemistry
-
Kidney Calculi / etiology*
-
Kidney Calculi / prevention & control
-
Male
-
Mutation
-
Parathyroid Hormone / blood
-
Rats
-
Receptors, Calcitriol / genetics
-
Thiazides / therapeutic use
-
Vitamin D / administration & dosage
-
Vitamin D / adverse effects*
-
Vitamin D / metabolism
-
Vitamin D Deficiency / therapy
-
Vitamin D3 24-Hydroxylase / genetics
-
Vitamin D3 24-Hydroxylase / metabolism
-
Vitamins / administration & dosage
-
Vitamins / adverse effects*
-
Vitamins / metabolism
Substances
-
Diphosphonates
-
Parathyroid Hormone
-
Receptors, Calcitriol
-
Thiazides
-
Vitamins
-
Vitamin D
-
CYP24A1 protein, human
-
Vitamin D3 24-Hydroxylase
-
Calcitriol
-
Calcium